期刊文献+

半乳糖基壳聚糖/5-氟尿嘧啶纳米粒抑制小鼠肝癌的实验研究 被引量:1

Experimental study of the inhibition of galactosylated chitosan/5-fluorouracil nanoparticles on liver cancer in mouse
下载PDF
导出
摘要 目的制备半乳糖基壳聚糖(GC)/5-氟尿嘧啶(5-Fu)纳米粒,观察其缓释特性及对小鼠肝癌的抑制作用。方法通过GC和5-Fu合成纳米粒,通过体外释放实验观察其缓释作用和体外实验观察GC/5-Fu纳米粒对肿瘤细胞抑制率和半数抑制率浓度值(IC50)。结果 GC/5-Fu纳米粒成功合成,呈规则的球形,表面光滑,大小均匀,纳米粒间无粘连。0~12 h出现突然快速释放,其累计释放率为32.4%;1~8 d出现平稳的缓慢释放,其累计释放率为93.50%;8~10 d呈平台期缓慢释放,10 d时累计释放率达95.70%。5-Fu和GC/5-Fu纳米粒对人结肠癌细胞株(SW480)和人肝癌细胞株(SMMC-7721)杀伤具有药物浓度越大,杀伤作用也就越强的量效依赖关系。在24 h、48 h和72 h,肿瘤抑制率从GC/5-Fu-SMMC-7721,5-Fu-SW480,5-Fu-SMMC-7721和GC/5-Fu-SW480依次降低。5-Fu的时间依赖性杀伤效应主要在1~6 d,在此期间的各个时相点,其IC50从GC/5-Fu-SMMC-7721,5-Fu-SW480,5-Fu-SMMC-7721和GC/5-Fu-SW480依次升高,但7 d后,5-Fu-SW480和5-Fu-SMMC-7721的时间依赖性杀伤效应进入一个平台期;而GC/5-Fu-SMMC-7721和GC/5-Fu-SW480的时间依赖性杀伤效应则从1~10 d呈持续增加趋势,并且6 d后,GC/5-Fu-SW480的IC50值小于5-Fu-SW480和5-Fu-SMMC-7721。结论 GC/5-Fu纳米粒具有缓释作用,体外对肿瘤细胞的杀伤作用具有量效依赖性和时间依赖性,对小鼠原位肝癌具有明显抑制作用,较5-Fu明显增强。 Objective It is to prepare the galactosylated chitosan (GC)/5 - fluorouracil (5 - Fu) nanoparticles, to observe its release characteristics and its effect on the inhibition of liver cancer in mice. Methods GC/5 - Fu nanoparticles were synthesized by GC and 5 - Fu, the sustained release in vitro were performed, the inhibition rate of tumor cells with the GC/5 - Fu nanoparticles and half inhibition rate of concentration value (1Cso) were observed in vitro. Results 5 - Fu/GC nanoparticles were successfully synthesized, electron microscopy showed that the particles were regular spherical shapes, with a smooth surface, a uniform size, and no adhesion between nanoparticles. A rapid release was observed from time 0 h to 12 h, with a cumulative release percentage of 32.4% ; a smooth slow-release occurred between day 1 and day 8, with a cumulative release percentage of 93.50%. During days 8 to 10, the release reached a plateau, with a cumulative release percentage of 95.70% at day 10. 5 - Fu and GC/5 - Fu inhibited the growth of SW480 and SMMC - 7721 ceils in a dose - dependent manner. At the 24, 48 and 72 h time points, the tumor cell inhibitory rate showed a decreased tendency from GC/5 - Fu - SMMC - 7721 to 5 - Fu - SW480 to 5 - Fu - SMMC - 7721 to GC/5 - Fu - SW480. 5 - Fu the time-dependent killing effect in the l to 6 d, the points during the IC50 from GC/5 - Fu - SMMC -7721 5 - Fu - of SW480, 5 - Fu - in SMMC - the 7721 GC/5 - Fu - SW480 turn increased, 5 - Fu - SW480 and 5 - Fu - of SMMC -7721 time-dependent killing effects into a plateau after 7 d; and GC/5 - Fu - SMMC the -7721 and GC/5 - Fu - SW480 of time dependent killing effect from the 1 for 10 days showed in- creasing trend, and 6 d after GC/5 - Fu - SW480 the IC50 value of less than 5 - Fu - SW480 5 - Fu - SMMC -7721. Conclusion GC/5 -Fu nanoparticles has a sustained release effect, and its hepatic cell -targeting cytotoxicity is dose and time dependent, it has a obviously inhibition on hepatocellular carcinoma in mouse, which was more obviously than that of 5 -Fu.
出处 《现代中西医结合杂志》 CAS 2012年第34期3790-3793,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 上海市自然科学基金资助项目(N09ZR1424700和114119a4700) 闵行区卫生局科学基金资助项目(2009MW28)
关键词 半乳糖基壳聚糖 5-氟尿嘧啶 纳米粒 肝癌 galactosylated chitosan 5- fluorouracil nanoparticles liver cancer
  • 相关文献

参考文献12

  • 1Nussbaumer S, Bonnabry P, Veuthey JL, et al. Analysis of antican- cer drugs : a review [ J ]. Talanta,2011,85 ( 5 ) :2265 - 2289.
  • 2Ruppova K, Wsolova L, Urbancikova M, et al. Comparison of three in vitro assays at evaluation of IC50 of acetylsalicylic acid, ferrous sulfate,amitriptyline, methanol, isopropanol and ethylene glycol in human eaneer cells HeLa [J].Neoplasma,2000,47 ( 3 ) : 172 - 176.
  • 3Li DC, Zhong XK, Zeng ZP, et al. Application of targeted drug de- livery system in Chinese medicine[ J ]. J Control Release,2009,138 (2) :103 -112.
  • 4Whitesides GM. The light'size in nanobiotechnology[ J]. Nat Bio- technol,2003,21 (10) :1161 - 1165.
  • 5Marcucci F,Lefoulon F. Active targeting with particulate drug carri- ers in tumor therapy: fundamentals and recent progress [ J ]. Drug Discov Today ,2004,9 ( 5 ) :219 - 228.
  • 6Alex SM, Rekha MR,Sharma CP. Spermine grafted galactosylated chitosan for improved nanoparticle mediated gene delivery[J]. Int J Pharm,2011,410(1/2) :125 - 137.
  • 7Jiang H, Wu H, Xu YL, et al. Preparation of galactosylated chi- tosan/tripolyphosphate nanoparticles and application as a gene carri- er for targeting SMMC7721 cells [ J ]. J Biosci Bioeng, 2011, 111 (6) :719 -724.
  • 8Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatin - loaded glycol chitosan nanoparticles in tumor-bearing mice [ J ]. J Control Release ,2008,127 ( 1 ) :41 - 49.
  • 9Managit C, Kawakami S, Yamashita F, et al. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells [ J ]. Int J Pharm ,2005,301 (1/2) :255 - 261.
  • 10Wang SL,Yu FB,Jiang TY, et al. Design and synthesis of novel galactosylated polymers for liposomes as gene drug carriers targeting the hepatic asialoglycoprotein receptor [ J ]. J Drug Target, 2008,16 (3) :233 -242.

同被引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部